Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Yassin

Showing results (531-540 of 553) with videos related to

Pageof 56
Sort By:
Clinical Medicine Insights. Blood Disorders|August 18, 2015
Dasatinib Induced Avascular Necrosis of Femoral Head in Adult Patient with Chronic Myeloid LeukemiaMohamed A Yassin, Abbas H Moustafa, Abdulqadir J Nashwan, et al.
European Review for Medical and Pharmacological Sciences|September 5, 2023
A randomized placebo-controlled, double-blind study to investigate the effect of a high oral loading dose of cholecalciferol in non-alcoholic fatty liver disease patients, new insights on serum STAT-3 and hepassocinS J Alarfaj, M M Bahaa, H A Yassin, et al.
Acta Bio-Medica : Atenei Parmensis|September 14, 2020
Prevalence, clinical manifestations, and biochemical data of type 2 diabetes mellitus versus nondiabetic symptomatic patients with COVID-19: A comparative studyAshraf T Soliman, Arun Prabhakaran Nair, Muna S Al Masalamani, et al.
European Journal of Medicinal Chemistry|October 30, 2025
Click-modifiable isatin hydrazones as COX-2, VEGFR-2, and carbonic anhydrase inhibitors: A multi-target approach to cancer therapyMaryam A Z El-Attar, Ola S Afifi, Azza Ismail, et al.
Acta Tropica|June 21, 2026
Oncostatin Level and Tumour Necrosis Factor-Alpha Gene Polymorphism in Predicting Blastocystis Infection in Inflammatory Bowel DiseaseAsmaa Ibrahim, Fatma Rageh, Shaymaa Abdelraheem Abdelhady, et al.
Clinical Medicine Insights. Oncology|October 11, 2016
Is Adherence to Imatinib Mesylate Treatment Among Patients with Chronic Myeloid Leukemia Associated with Better Clinical Outcomes in Qatar?Nader I Al-Dewik, Hisham M Morsi, Muthanna M Samara, et al.
Acta Bio-Medica : Atenei Parmensis|July 2, 2021
The Prevalence of glucose dysregulations (GDs) in patients with β-thalassemias in different countries: A preliminary ICET-A surveyVincenzo De Sanctis, Ashraf Soliman, Ploutarchos Tzoulis, et al.
Leukemia|February 22, 2024
Chronic myeloid leukemia diagnosed in pregnancy: management and outcome of 87 patients reported to the European LeukemiaNet international registryEkaterina Chelysheva, Jane Apperley, Anna Turkina, et al.
Infectious Diseases of Poverty|March 25, 2016
Patients direct costs to undergo TB diagnosisRachel M Anderson de Cuevas, Lovett Lawson, Najla Al-Sonboli, et al.
Clinical Medicine Insights. Case Reports|September 18, 2015
Cytomegalovirus-induced Hemorrhagic Colitis in a Patient with Chronic Myeloid Leukemia (Chronic Phase) on Dasatinib as an Upfront TherapyMohamed A Yassin, Abdulqadir J Nashwan, Ashraf T Soliman, et al.
Pageof 56

Showing results (531-540 of 553) with videos related to

Sort By:
Pageof 56
Clinical Medicine Insights. Blood Disorders|August 18, 2015
Dasatinib Induced Avascular Necrosis of Femoral Head in Adult Patient with Chronic Myeloid LeukemiaMohamed A Yassin, Abbas H Moustafa, Abdulqadir J Nashwan, et al.
European Review for Medical and Pharmacological Sciences|September 5, 2023
A randomized placebo-controlled, double-blind study to investigate the effect of a high oral loading dose of cholecalciferol in non-alcoholic fatty liver disease patients, new insights on serum STAT-3 and hepassocinS J Alarfaj, M M Bahaa, H A Yassin, et al.
Acta Bio-Medica : Atenei Parmensis|September 14, 2020
Prevalence, clinical manifestations, and biochemical data of type 2 diabetes mellitus versus nondiabetic symptomatic patients with COVID-19: A comparative studyAshraf T Soliman, Arun Prabhakaran Nair, Muna S Al Masalamani, et al.
European Journal of Medicinal Chemistry|October 30, 2025
Click-modifiable isatin hydrazones as COX-2, VEGFR-2, and carbonic anhydrase inhibitors: A multi-target approach to cancer therapyMaryam A Z El-Attar, Ola S Afifi, Azza Ismail, et al.
Acta Tropica|June 21, 2026
Oncostatin Level and Tumour Necrosis Factor-Alpha Gene Polymorphism in Predicting Blastocystis Infection in Inflammatory Bowel DiseaseAsmaa Ibrahim, Fatma Rageh, Shaymaa Abdelraheem Abdelhady, et al.
Clinical Medicine Insights. Oncology|October 11, 2016
Is Adherence to Imatinib Mesylate Treatment Among Patients with Chronic Myeloid Leukemia Associated with Better Clinical Outcomes in Qatar?Nader I Al-Dewik, Hisham M Morsi, Muthanna M Samara, et al.
Acta Bio-Medica : Atenei Parmensis|July 2, 2021
The Prevalence of glucose dysregulations (GDs) in patients with β-thalassemias in different countries: A preliminary ICET-A surveyVincenzo De Sanctis, Ashraf Soliman, Ploutarchos Tzoulis, et al.
Leukemia|February 22, 2024
Chronic myeloid leukemia diagnosed in pregnancy: management and outcome of 87 patients reported to the European LeukemiaNet international registryEkaterina Chelysheva, Jane Apperley, Anna Turkina, et al.
Infectious Diseases of Poverty|March 25, 2016
Patients direct costs to undergo TB diagnosisRachel M Anderson de Cuevas, Lovett Lawson, Najla Al-Sonboli, et al.
Clinical Medicine Insights. Case Reports|September 18, 2015
Cytomegalovirus-induced Hemorrhagic Colitis in a Patient with Chronic Myeloid Leukemia (Chronic Phase) on Dasatinib as an Upfront TherapyMohamed A Yassin, Abdulqadir J Nashwan, Ashraf T Soliman, et al.
Pageof 56